CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Conjunctivitis - allergic - Management
What are the adverse effects of topical ocular mast cell stabilizers?
- In the unlikely event that the use of a topical ocular mast cell stabilizer causes transient vision changes, advise the person to wait until these changes resolve before driving or operating machinery.
- Lodoxamide — the most frequently reported ocular adverse effects are transient burning, stinging, or discomfort upon instillation, which occur in 13% of people using the eye drops [ABPI Medicines Compendium, 2002b].
- Transient stinging and burning may also occur after instillation of nedocromil sodium or sodium cromoglicate [ABPI Medicines Compendium, 2004a; ABPI Medicines Compendium, 2004b].
- An unpleasant taste immediately after instillation of nedocromil sodium eye drops has been reported [Wormald et al, 2004].
© NHS Institute for Innovation and Improvement